India approves AstraZeneca vaccine as company still working on jab’s efficacy after disappointing trial results ...News

Russia Today - News
India approves AstraZeneca vaccine as company still working on jab’s efficacy after disappointing trial results
India has approved AstraZeneca’s Covid-19 jab for emergency use, despite confusion over its efficacy ranging from 62 to 90 percent in trials. AstraZeneca claims to have discovered a “winning formula,” but hasn’t revealed it yet. India’s information minister, Prakash Javadekar, announced on Saturday that the coronavirus vaccine, designed by the British-Swedish drugmaker AstraZeneca in collaboration with the University of Oxford, had been approved by regulators a day earlier for emergency use. Formal approval by the Drugs Controller General of India is expected in the coming days. The news came as India surpassed its 10 millionth case of

Read More Details
Finally We wish PressBee provided you with enough information of ( India approves AstraZeneca vaccine as company still working on jab’s efficacy after disappointing trial results )

Apple Storegoogle play

Also on site :